Abbott Medical Devices clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
5 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 2 with minor changes only.
- Notable: CROWN-MV · TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System Phase changed: Not specified → Not applicable
- Notable: VOYAGER CE · Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR Enrollment increased: 150 → 300 participants
- Minor: TREAT TR · Post-Market Assessment of the Safety and Performance of the TriClip™ System Trial sites expanded: 9 → 14 locations
- Notable: VOLT CE Mark Study Primary completion pushed from Jun 2026 to Jan 2027
- Minor: BLAST-OFF · BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 68 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Heart Disease (57) · Atrial Fibrillation (9) · Heart Failure (8) · Stroke (3) · Coronary Artery Disease (2) · Parkinson's Disease (2) · Depression (1) · Hypertension (1)
Get alerts when Abbott Medical Devices's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.